Payne, Matthew
Pooke, Francis
Wilkinson, Tom M.
Holder-Pearson, Lui
Chamberlain, Bronté
de Bock, Martin
Chase, J. Geoffrey
Funding for this research was provided by:
NZ National Science Challenge 7, Science for Technology, and Innovation (2019-S3-CRS, 2019-S3-CRS, 2019-S3-CRS, 2019-S3-CRS, 2019-S3-CRS, 2019-S3-CRS)
University of Canterbury (Doctoral Scholarship)
Article History
Received: 4 April 2024
Accepted: 9 July 2024
First Online: 1 August 2024
Declarations
:
: Ethics approval for this study was granted by the New Zealand Human Disability Ethics Committee (Ethics reference: 2023 FULL 19050). The trial was prospectively registered with the Australian New Zealand Clinical Trials Registry (ACTRN12623001288617) on the 11 December 2023 and was carried out in conformity with the ethical principles of the Declaration of Helsinki. Informed consent was obtained from all participants.
: Not applicable.
: The authors declare no competing interests.